tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of James Quigley, 40 are a HOLD (56.34%), 26 are a BUY (36.62%), 5 are a SELL (7.04%).
Analyst James Quigley, currently employed at GOLDMAN SACHS, carries an average stock price target met ratio of 42.66% that have a potential upside of 21.07% achieved within 160 days.
James Quigley’s has documented 131 price targets and ratings displayed on 8 stocks. The coverage is on Healthcare, Consumer Defensive sectors.
Most recent stock forecast was given on NVO, Novo Nordisk A/S at 02-Mar-2026.
Analyst best performing recommendations are on KYMR (KYMERA THERAPEUTICS).
The best stock recommendation documented was for GLPG (GALAPAGOS NV ADR) at 8/7/2023. The price target of $40 was fulfilled within 1 day with a profit of $0.43 (1.06%) receiving and performance score of 10.64.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Jun-2023
$17
$-1.96 (-10.34%)
$17
2 years 1 months 27 days ago
(05-Feb-2024)
3/3 (100%)
$-0.27 (-1.56%)
96
Hold Since 16-Jan-2024
$38.28
2 years 2 months 13 days ago
(19-Jan-2024)
5/9 (55.56%)
$27.51 (255.43%)
398
Buy Since 16-Jun-2023
$33.57
$14.61 (77.06%)
$10
2 years 3 months 27 days ago
(05-Dec-2023)
3/5 (60%)
$25.99 (342.88%)
376
Buy Since 16-Jun-2023
$8.5
$-10.46 (-55.17%)
$10
2 years 3 months 27 days ago
(05-Dec-2023)
2/4 (50%)
$0.92 (12.14%)
106
Hold
$4.75
$-13.1 (-73.39%)
2 years 4 months 10 days ago
(22-Nov-2023)
1/2 (50%)
$0.2 (4.40%)
5
Which stock is James Quigley is most bullish on?
What Year was the first public recommendation made by James Quigley?
